Analytical Data
-
Gene name
FER
- Application
-
Alternative Names
(Feline encephalitis virus-related kinase FER)(Fujinami poultry sarcoma/Feline sarcoma-related protein Fer)(Proto-oncogene c-Fer)(Tyrosine kinase 3)(p94-Fer)
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P16591
-
Expression Region
563-816aa
-
Molecular Weight
33.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on the recombinant protein of FER (FES-related) has gained significant attention due to its potential implications in various biological processes and disease mechanisms. FER is a member of the ETS transcription factor family, known for its role in regulating gene expression, cell proliferation, and differentiation. It has been implicated in several pathological conditions, including cancer, where its expression levels and activity may influence tumorigenesis and metastasis. The understanding of FER's biological functions necessitated the development of recombinant proteins, which provide a controlled and purified source for studying its molecular interactions and cellular effects. By utilizing recombinant DNA technology, researchers can produce FER proteins in host systems, allowing for detailed biochemical characterization, functional assays, and therapeutic development. The study of FER recombinant proteins not only aids in dissecting the signaling pathways associated with its activity but also paves the way for targeted therapies in diseases where FER dysregulation is a contributing factor. Thus, the exploration of FER recombinant proteins is critical for elucidating their roles in health and disease, ultimately leading to advancements in clinical interventions.
